Ramzi Haidamus Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ramzi Haidamus.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ramzi Haidamus. Ramzi Haidamus is President and CEO in IMMERSION CORP ($IMMR) and EVP, Marketing and Bus. Dev. in Dolby Laboratories, Inc. ($DLB) and EVP, Sales and Marketing in Dolby Laboratories, Inc. ($DLB) and Sr. V.P. & G.M., Consumer Div. in Dolby Laboratories, Inc. ($DLB) and V.P. & G.M., Consumer Division in Dolby Laboratories, Inc. ($DLB).
Latest Insider Trading Transactions of Ramzi Haidamus
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Option Exercise | M | 0.00 | 17,610 | 0 | 158,491 | |
Oct 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Sell | S | 7.00 | 8,845 | 61,915 | 65,008 | 73.9 K to 65 K (-11.98 %) |
Oct 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Buy | M | 0.00 | 17,610 | 0 | 73,853 | 56.2 K to 73.9 K (+31.31 %) |
Sep 15 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Sell | S | 8.29 | 10,000 | 82,904 | 56,243 | 66.2 K to 56.2 K (-15.10 %) |
Jul 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Option Exercise | M | 0.00 | 17,610 | 0 | 176,101 | |
Jul 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Sell | S | 6.69 | 8,970 | 59,998 | 66,243 | 75.2 K to 66.2 K (-11.93 %) |
Jul 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Buy | M | 0.00 | 17,610 | 0 | 75,213 | 57.6 K to 75.2 K (+30.57 %) |
Apr 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Option Exercise | M | 0.00 | 17,610 | 0 | 193,711 | |
Apr 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Sell | S | 6.03 | 7,611 | 45,894 | 57,603 | 65.2 K to 57.6 K (-11.67 %) |
Apr 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Buy | M | 0.00 | 17,610 | 0 | 65,214 | 47.6 K to 65.2 K (+36.99 %) |
Mar 11 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Option Exercise | A | 7.54 | 316,056 | 2,382,430 | 316,056 | |
Mar 11 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Option Exercise | A | 0.00 | 44,176 | 0 | 44,176 | |
Jan 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Option Exercise | M | 0.00 | 70,441 | 0 | 211,321 | |
Jan 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Payment of Exercise | F | 7.55 | 25,637 | 193,559 | 47,604 | 73.2 K to 47.6 K (-35.00 %) |
Jan 23 2020 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Buy | M | 0.00 | 70,441 | 0 | 73,241 | 2.8 K to 73.2 K (+2,515.75 %) |
Dec 17 2019 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Buy | P | 7.00 | 2,800 | 19,586 | 2,800 | 0 to 2.8 K |
Feb 15 2019 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Option Exercise | A | 9.82 | 268,992 | 2,641,501 | 268,992 | |
Feb 15 2019 | IMMR | IMMERSION CORP | Haidamus Ramzi | President and CEO | Option Exercise | A | 0.00 | 281,762 | 0 | 281,762 | |
Mar 20 2013 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Marketing and ... | Sell | S | 32.50 | 1,560 | 50,703 | 113,477 | 115 K to 113.5 K (-1.36 %) |
Mar 19 2013 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Marketing and ... | Payment of Exercise | F | 32.76 | 940 | 30,794 | 115,037 | 116 K to 115 K (-0.81 %) |
Feb 12 2013 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Marketing and ... | Sell | S | 30.85 | 2,431 | 74,988 | 115,977 | 118.4 K to 116 K (-2.05 %) |
Feb 12 2013 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Marketing and ... | Payment of Exercise | F | 31.74 | 1,569 | 49,800 | 118,408 | 120 K to 118.4 K (-1.31 %) |
Dec 21 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Marketing and ... | Option Exercise | A | 30.49 | 74,000 | 2,256,260 | 74,000 | |
Dec 21 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Marketing and ... | Grant | A | 0.00 | 17,300 | 0 | 119,977 | 102.7 K to 120 K (+16.85 %) |
Dec 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Marketing and ... | Sell | S | 35.21 | 6,790 | 239,082 | 102,677 | 109.5 K to 102.7 K (-6.20 %) |
Dec 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Marketing and ... | Payment of Exercise | F | 35.34 | 3,935 | 139,063 | 109,467 | 113.4 K to 109.5 K (-3.47 %) |
Aug 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | A | 34.54 | 84,000 | 2,901,360 | 84,000 | |
Aug 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 21,000 | 0 | 113,402 | 92.4 K to 113.4 K (+22.73 %) |
Aug 14 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | D | 66.63 | 60,000 | 3,997,800 | 0 | |
Aug 14 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | D | 51.19 | 72,000 | 3,685,680 | 0 | |
Aug 14 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | D | 48.15 | 13,500 | 650,025 | 0 | |
Aug 14 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 16,666 | 0 | 92,402 | 75.7 K to 92.4 K (+22.01 %) |
Aug 14 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 21,818 | 0 | 75,736 | 53.9 K to 75.7 K (+40.47 %) |
Aug 14 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 4,218 | 0 | 53,918 | 49.7 K to 53.9 K (+8.49 %) |
Jun 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 937 | 29,900 | 8,438 | |
Jun 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 42.14 | 937 | 39,485 | 49,700 | 50.6 K to 49.7 K (-1.85 %) |
Jun 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 937 | 29,900 | 50,637 | 49.7 K to 50.6 K (+1.89 %) |
May 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 938 | 29,932 | 9,375 | |
May 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 44.98 | 938 | 42,191 | 49,700 | 50.6 K to 49.7 K (-1.85 %) |
May 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 938 | 29,932 | 50,638 | 49.7 K to 50.6 K (+1.89 %) |
Apr 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 937 | 29,900 | 10,313 | |
Apr 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 36.91 | 937 | 34,585 | 49,700 | 50.6 K to 49.7 K (-1.85 %) |
Apr 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 937 | 29,900 | 50,637 | 49.7 K to 50.6 K (+1.89 %) |
Mar 20 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 38.90 | 1,583 | 61,586 | 49,700 | 51.3 K to 49.7 K (-3.09 %) |
Mar 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 938 | 29,932 | 11,250 | |
Mar 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 38.89 | 917 | 35,662 | 51,283 | 52.2 K to 51.3 K (-1.76 %) |
Mar 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 39.08 | 938 | 36,657 | 52,200 | 53.1 K to 52.2 K (-1.77 %) |
Mar 19 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 938 | 29,932 | 53,138 | 52.2 K to 53.1 K (+1.80 %) |
Feb 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 937 | 29,900 | 12,188 | |
Feb 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 38.09 | 937 | 35,690 | 52,200 | 53.1 K to 52.2 K (-1.76 %) |
Feb 17 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | M | 31.91 | 937 | 29,900 | 53,137 | 54.1 K to 53.1 K (-1.73 %) |
Feb 10 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 38.10 | 2,528 | 96,327 | 52,200 | 54.7 K to 52.2 K (-4.62 %) |
Feb 09 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 11,250 | 358,988 | 13,125 | |
Feb 09 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 38.41 | 1,472 | 56,540 | 54,728 | 56.2 K to 54.7 K (-2.62 %) |
Feb 09 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 38.40 | 11,250 | 431,948 | 56,200 | 67.5 K to 56.2 K (-16.68 %) |
Feb 09 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 11,250 | 358,988 | 67,450 | 56.2 K to 67.5 K (+20.02 %) |
Feb 08 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 37.98 | 871 | 33,081 | 56,200 | 57.1 K to 56.2 K (-1.53 %) |
Feb 08 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 37.48 | 8,674 | 325,102 | 57,071 | 65.7 K to 57.1 K (-13.19 %) |
Feb 08 2012 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 37.81 | 629 | 23,782 | 65,745 | 66.4 K to 65.7 K (-0.95 %) |
Dec 19 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | A | 31.45 | 121,200 | 3,811,740 | 121,200 | |
Dec 19 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 28,100 | 0 | 66,374 | 38.3 K to 66.4 K (+73.42 %) |
Dec 19 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 31.45 | 1,358 | 42,709 | 38,274 | 39.6 K to 38.3 K (-3.43 %) |
Mar 17 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 48.83 | 3,668 | 179,108 | 39,632 | 43.3 K to 39.6 K (-8.47 %) |
Feb 11 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 54.18 | 2,532 | 137,184 | 43,300 | 45.8 K to 43.3 K (-5.52 %) |
Feb 10 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 54.81 | 905 | 49,603 | 45,832 | 46.7 K to 45.8 K (-1.94 %) |
Feb 09 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 54.93 | 1,468 | 80,637 | 46,737 | 48.2 K to 46.7 K (-3.05 %) |
Feb 09 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 55.12 | 595 | 32,796 | 48,205 | 48.8 K to 48.2 K (-1.22 %) |
Jan 19 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 938 | 29,932 | 24,375 | |
Jan 19 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 60.70 | 938 | 56,937 | 48,800 | 49.7 K to 48.8 K (-1.89 %) |
Jan 19 2011 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 938 | 29,932 | 49,738 | 48.8 K to 49.7 K (+1.92 %) |
Dec 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 937 | 29,900 | 25,313 | |
Dec 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 66.45 | 937 | 62,264 | 48,800 | 49.7 K to 48.8 K (-1.88 %) |
Dec 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 937 | 29,900 | 49,737 | 48.8 K to 49.7 K (+1.92 %) |
Dec 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | A | 66.63 | 60,000 | 3,997,800 | 60,000 | |
Dec 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 14,800 | 0 | 48,800 | 34 K to 48.8 K (+43.53 %) |
Nov 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 938 | 29,932 | 26,250 | |
Nov 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 64.00 | 938 | 60,032 | 34,000 | 34.9 K to 34 K (-2.68 %) |
Nov 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | M | 31.91 | 938 | 29,932 | 34,938 | 35.9 K to 34.9 K (-2.61 %) |
Nov 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 28.13 | 13,750 | 386,788 | 0 | |
Nov 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 64.88 | 13,750 | 892,147 | 34,000 | 47.8 K to 34 K (-28.80 %) |
Nov 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | M | 28.13 | 13,750 | 386,788 | 47,750 | 61.5 K to 47.8 K (-22.36 %) |
Oct 19 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 937 | 29,900 | 27,188 | |
Oct 19 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 61.29 | 937 | 57,429 | 34,000 | 34.9 K to 34 K (-2.68 %) |
Oct 19 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | M | 31.91 | 937 | 29,900 | 34,937 | 35.9 K to 34.9 K (-2.61 %) |
Sep 22 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 938 | 29,932 | 28,125 | |
Sep 22 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 56.91 | 938 | 53,382 | 34,000 | 34.9 K to 34 K (-2.68 %) |
Sep 22 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | M | 31.91 | 938 | 29,932 | 34,938 | 35.9 K to 34.9 K (-2.61 %) |
Aug 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 937 | 29,900 | 29,063 | |
Aug 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 56.92 | 37 | 2,106 | 34,000 | 34 K to 34 K (-0.11 %) |
Aug 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 56.91 | 900 | 51,219 | 34,037 | 34.9 K to 34 K (-2.58 %) |
Aug 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | M | 31.91 | 937 | 29,900 | 34,937 | 35.9 K to 34.9 K (-2.61 %) |
Jul 20 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 938 | 29,932 | 30,000 | |
Jul 20 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 66.92 | 938 | 62,771 | 34,000 | 34.9 K to 34 K (-2.68 %) |
Jul 20 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | M | 31.91 | 938 | 29,932 | 34,938 | 35.9 K to 34.9 K (-2.61 %) |
Jun 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 937 | 29,900 | 30,938 | |
Jun 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 68.77 | 937 | 64,437 | 34,000 | 34.9 K to 34 K (-2.68 %) |
Jun 17 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | M | 31.91 | 937 | 29,900 | 34,937 | 35.9 K to 34.9 K (-2.61 %) |
Jun 01 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 63.79 | 4,748 | 302,875 | 34,000 | 38.7 K to 34 K (-12.25 %) |
Jun 01 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 63.79 | 4,748 | 302,875 | 34,000 | 38.7 K to 34 K (-12.25 %) |
May 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 937 | 29,900 | 31,875 | |
May 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 64.73 | 937 | 60,652 | 38,748 | 39.7 K to 38.7 K (-2.36 %) |
May 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 937 | 29,900 | 39,685 | 38.7 K to 39.7 K (+2.42 %) |
May 03 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 48.15 | 13,500 | 650,025 | 13,500 | |
May 03 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 68.31 | 13,500 | 922,185 | 38,748 | 52.2 K to 38.7 K (-25.84 %) |
May 03 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 48.15 | 13,500 | 650,025 | 52,248 | 38.7 K to 52.2 K (+34.84 %) |
Apr 19 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 938 | 29,932 | 32,812 | |
Apr 19 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 59.07 | 938 | 55,408 | 38,748 | 39.7 K to 38.7 K (-2.36 %) |
Apr 19 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 938 | 29,932 | 39,686 | 38.7 K to 39.7 K (+2.42 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 31.91 | 11,250 | 358,988 | 33,750 | |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 58.47 | 200 | 11,694 | 34,000 | 34.2 K to 34 K (-0.58 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 58.46 | 400 | 23,384 | 34,200 | 34.6 K to 34.2 K (-1.16 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 58.45 | 200 | 11,690 | 34,600 | 34.8 K to 34.6 K (-0.57 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 58.44 | 300 | 17,532 | 34,800 | 35.1 K to 34.8 K (-0.85 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 58.43 | 1,200 | 70,116 | 35,100 | 36.3 K to 35.1 K (-3.31 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 58.42 | 500 | 29,210 | 36,300 | 36.8 K to 36.3 K (-1.36 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 58.41 | 2,694 | 157,357 | 36,800 | 39.5 K to 36.8 K (-6.82 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 58.41 | 700 | 40,887 | 39,494 | 40.2 K to 39.5 K (-1.74 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 57.06 | 3,806 | 217,170 | 40,194 | 44 K to 40.2 K (-8.65 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 56.83 | 11,250 | 639,338 | 44,000 | 55.3 K to 44 K (-20.36 %) |
Mar 18 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 31.91 | 11,250 | 358,988 | 55,250 | 44 K to 55.3 K (+25.57 %) |
Feb 10 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 20.38 | 5,000 | 101,900 | 0 | |
Feb 10 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 51.17 | 5,949 | 304,410 | 44,000 | 49.9 K to 44 K (-11.91 %) |
Feb 10 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 20.38 | 5,000 | 101,900 | 49,949 | 44.9 K to 49.9 K (+11.12 %) |
Feb 08 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | A | 51.19 | 72,000 | 3,685,680 | 72,000 | |
Feb 08 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 16,000 | 0 | 44,949 | 28.9 K to 44.9 K (+55.27 %) |
Feb 08 2010 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 52.42 | 551 | 28,883 | 28,949 | 29.5 K to 28.9 K (-1.87 %) |
Dec 02 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 28.13 | 13,750 | 386,788 | 13,750 | |
Dec 02 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 45.04 | 11 | 495 | 29,500 | 29.5 K to 29.5 K (-0.04 %) |
Dec 02 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 45.01 | 600 | 27,006 | 29,511 | 30.1 K to 29.5 K (-1.99 %) |
Dec 02 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 45.00 | 13,139 | 591,255 | 30,111 | 43.3 K to 30.1 K (-30.38 %) |
Dec 02 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 28.13 | 13,750 | 386,788 | 43,250 | 29.5 K to 43.3 K (+46.61 %) |
Oct 26 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 28.13 | 13,750 | 386,788 | 27,500 | |
Oct 26 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 45.00 | 13,750 | 618,750 | 29,500 | 43.3 K to 29.5 K (-31.79 %) |
Oct 26 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 28.13 | 13,750 | 386,788 | 43,250 | 29.5 K to 43.3 K (+46.61 %) |
Aug 14 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 20.38 | 5,000 | 101,900 | 5,000 | |
Aug 14 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 40.38 | 5,000 | 201,900 | 29,500 | 34.5 K to 29.5 K (-14.49 %) |
Aug 14 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 20.38 | 5,000 | 101,900 | 34,500 | 29.5 K to 34.5 K (+16.95 %) |
Aug 11 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 19.20 | 5,500 | 105,600 | 0 | |
Aug 11 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 40.00 | 963 | 38,520 | 29,500 | 30.5 K to 29.5 K (-3.16 %) |
Aug 11 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 39.78 | 5,500 | 218,790 | 30,463 | 36 K to 30.5 K (-15.29 %) |
Aug 11 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Buy | M | 19.20 | 5,500 | 105,600 | 35,963 | 30.5 K to 36 K (+18.05 %) |
Mar 18 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | A | 31.91 | 45,000 | 1,435,950 | 45,000 | |
Mar 18 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 15,000 | 0 | 30,463 | 15.5 K to 30.5 K (+97.01 %) |
Mar 18 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Grant | A | 0.00 | 10,000 | 0 | 15,463 | 5.5 K to 15.5 K (+183.05 %) |
Feb 09 2009 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Payment of Exercise | F | 30.18 | 537 | 16,207 | 5,463 | 6 K to 5.5 K (-8.95 %) |
Jul 02 2008 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Option Exercise | M | 19.20 | 5,500 | 105,600 | 5,500 | |
Jul 02 2008 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 38.77 | 100 | 3,877 | 6,000 | 6.1 K to 6 K (-1.64 %) |
Jul 02 2008 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 38.75 | 400 | 15,500 | 6,100 | 6.5 K to 6.1 K (-6.15 %) |
Jul 02 2008 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 40.07 | 500 | 20,035 | 6,500 | 7 K to 6.5 K (-7.14 %) |
Jul 02 2008 | DLB | Dolby Laboratories ... | Haidamus Ramzi | EVP, Sales and Mark ... | Sell | S | 40.00 | 500 | 20,000 | 7,000 | 7.5 K to 7 K (-6.67 %) |